ANGITIA
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ANGITIA Trademark

Serial Number: 90681693

ANGITIA is a trademark filed by Angitia Biopharmaceuticals Guangzhou Limited on April 29, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Angitia Biopharmaceuticals Guangzhou Limited (10 trademarks)

Room 202-302, Building 4
Guangzhou, Guangdong 510530 , CN

Entity Type: 16

Trademark Details

Filing Date

April 29, 2021

Registration Date

Not Registered

Published for Opposition

July 26, 2022

Goods & Services

Allergy tablets; Anti-inflammatory ointments; Anti-itch ointment; Antibiotic ointments; Antibiotic tablets; Biological tissue grafts; Bone cement for medical purposes; Bone cement for surgical and orthopaedic purposes; Bone growth media consisting of biological materials for medical purposes; Cement for bones for medical use; Ceramic materials for dental use for fillings; Drug delivery agents in the form of injections solutions that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of ointment suspensions that facilitate the delivery of pharmaceutical preparations; Hemorrhoidal ointments; Materials for dental fillings; Materials for dental fillings and for sealing purposes; Medical dressings; Medicated ointments for treating dermatological conditions; Medicated sunburn ointments; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Mentholated ointment for medical use; Mercurial ointments for medical use; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritive substances for micro-organisms for medical use; Nutritive substances for microorganisms for medical purposes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Skin grafts; Synthetic materials for dental use for fillings; Thyroid and para-thyroid hormone preparations; Tumor suppressing agents; Vascular grafts; Veterinary pharmaceutical preparations for the prevention of cardiovascular disorders, immune disorders, infection, nervous system disorders; Veterinary pharmaceutical preparations for the treatment of cardiovascular disorders, immune disorders, infection, nervous system disorders, anxiety disorders, cancer; Veterinary preparations, namely, pain relief medication; Vitamin D preparations

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 24, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 24, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 26, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 6, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 28, 2021 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 10, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 10, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 10, 2021 REAP
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 5, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 4, 2021 NWOS
NEW APPLICATION ENTERED
May 3, 2021 NWAP